North America Hyperphosphatemia Drug Market Forecast 2019-2027

Publisher Name :
Date: 19-Nov-2018
No. of pages: 80

Key Findings

The North America hyperphosphatemia drug market is expected to grow at a CAGR of 15.19% over the forecast period. The region is expected to hold the largest share in the market with an anticipated increase in the revenue from $xx million in 2018 to $xx million by 2027. Diabetes and hypertension are the main causes of renal failure, which in turn leads to hyperphosphatemia. Increasing prevalence of these chronic diseases along with unattended medical needs are driving the hyperphosphatemia drug market in this region.

Market Insights

The changing dietary patterns along with the increasing cases of osteoporosis diseases in countries like the United States and Canada are providing the hyperphosphatemia drug market with plenty of growth opportunities. The market is mainly categorized by the different types of drug binders such as iron-based phosphate binders, magnesium-based phosphate binders, aluminium-based phosphate binders, calcium-based phosphate binders and others. The aluminium-based phosphate binders generated revenue of $203 million in 2016 and are widely used with magnesium-based phosphate binders for treating patients on dialysis. However, it is the calcium-based phosphate binders that held the largest market share of xx% in 2018 and are expected to continue their dominance throughout the forecasted period. Despite such phenomenal growth, the market is facing some tough challenges due to the various limitations imposed by the Food and Drug Administration (FDA) and the rising side effects observed due to the use of some of the hyperphosphatemia drugs.

Competitive Insights

Some of the eminent companies in the hyperphosphatemia drug market include Royal Dsm, Amag, Sun Pharma, and Keryx. Other top players in the market are Zeria Pharmaceutical, Johnson and Johnson, Bruno Pharmaceutical Spa, Cipla, Ultragenyx, Fresenius Medical Care, Roche Diagnostics Corporation, R.H. Moore Drug Co., Sanofi, Fermenta Biotech Ltd, Vifor Pharma, Shire and Pfizer Inc.

North America Hyperphosphatemia Drug Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Iron-Based Hyperphosphatemia Drugs Is A Game Changer
4. Market Determinants
4.1. Market Scope & Definition
4.2. Drivers
4.2.1. Growing Prevalence of Chronic Diseases
4.2.2. Unmet Medical Needs
4.2.3. Skewed Population Mix Towards Elderly People
4.2.4. Rise In Public Awareness
4.3. Restraints
4.3.1. Limitations Levied By The Food And Drug Administration (Fda)
4.3.2. Growing Side Effects of The Hyperphosphatemia Drugs
4.4. Challenges
4.4.1. Non-Adherence To Treatment Regimens
4.4.2. Side Effects of Drugs
4.4.3. Limited Availability of Drugs
4.4.4. Use of Advanced Dialysis Techniques
4.5. Market By Dosage
4.5.1. Solid
4.5.1.1. Tablet
4.5.1.2. Powder
4.5.2. Liquid
4.5.2.1. Solution
5. Market By Formulation
5.1.1. Calcium-Based Phosphate Binders
5.1.2. Aluminum-Based Phosphate Binders
5.1.3. Magnesium-Based Phosphate Binders
5.1.4. Iron-Based Phosphate Binders
5.1.5. Other Phosphate Binders
6. Key Analytics
6.1. Porter's Five Force Model
6.1.1. Threat of New Entrants
6.1.2. Bargaining Power of Buyers
6.1.3. Bargaining Power of Suppliers
6.1.4. Threat of Substitute Product
6.1.5. Intensity of Competitive Rivalry
6.2. Opportunity Matrix
6.3. Key Buying Criteria
6.3.1. Application
6.3.2. Pricing
6.3.3. Effectiveness
6.3.4. Availability
6.4. Strategic Recommendation & Strategic Conclusions
6.5. Market Trends
6.5.1. Patient Assistance Programs
6.5.2. Strategic Alliances
6.5.3. Increase In R&D
6.6. Phosphate Binders Usages Guidelines
7. Geographic Analysis
7.1. North America
7.1.1. The United States
7.1.2. Canada
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Company Profiles
8.2.1. Amag Pharmaceuticals
8.2.1.1. Overview
8.2.1.2. Product Portfolio
8.2.1.3. Scot Analysis
8.2.1.4. Strategic Initiatives
8.2.2. Biotech Pharmacal
8.2.2.1. Overview
8.2.2.2. Products Portfolio
8.2.2.3. Scot Analysis
8.2.2.4. Strategic Initiatives
8.2.3. Bruno Farmaceutici Spa
8.2.3.1. Overview
8.2.3.2. Product Portfolio
8.2.3.3. Scot Analysis
8.2.3.4. Strategic Initiatives
8.2.4. Cipla
8.2.4.1. Overview
8.2.4.2. Product Portfolio
8.2.4.3. Scot Analysis
8.2.4.4. Strategic Initiatives
8.2.5. Fermenta Biotech Ltd
8.2.5.1. Overview
8.2.5.2. Product Portfolio
8.2.5.3. Scot Analysis
8.2.5.4. Strategic Initiatives
8.2.6. Fresenius Medical Care
8.2.6.1. Overview
8.2.6.2. Product Portfolio
8.2.6.3. Scot Analysis
8.2.6.4. Strategic Initiatives
8.2.7. Johnson And Johnson
8.2.7.1. Company Overview
8.2.7.2. Product Portfolio
8.2.7.3. Scot Analysis
8.2.7.4. Strategic Initiatives
8.2.8. Keryx Biopharmaceuticals Inc
8.2.8.1. Overview
8.2.8.2. Scot Analysis
8.2.8.3. Strategic Initiatives
8.2.9. Pfizer Inc.
8.2.9.1. Overview
8.2.9.2. Product Portfolio
8.2.9.3. Scot Analysis
8.2.9.4. Strategic Initiatives
8.2.10. Roche Diagnostics Corporation
8.2.10.1. Overview
8.2.10.2. Product Portfolio
8.2.10.3. Scot Analysis
8.2.10.4. Strategic Initiatives
8.2.11. Royal Dsm N.V.
8.2.11.1. Overview
8.2.11.2. Product Portfolio
8.2.11.3. Scot Analysis
8.2.11.4. Strategic Initiatives
8.2.12. Sanofi
8.2.12.1. Overview
8.2.12.2. Product Portfolio
8.2.12.3. Scot Analysis
8.2.12.4. Strategic Initiatives
8.2.13. Shire
8.2.13.1. Overview
8.2.13.2. Product Portfolio
8.2.13.3. Scot Analysis
8.2.13.4. Strategic Initiatives
8.2.14. Sun Pharmaceutical Industries Ltd
8.2.14.1. Overview
8.2.14.2. Products Portfolio
8.2.14.3. Scot Analysis
8.2.14.4. Strategic Initiatives
8.2.15. Ultragenyx Pharmaceutical Inc.
8.2.15.1. Overview
8.2.15.2. Product Portfolio
8.2.15.3. Scot Analysis
8.2.15.4. Strategic Initiatives
8.2.16. Zeria Pharmaceutical
8.2.16.1. Overview
8.2.16.2. Product Portfolio
8.2.16.3. Scot Analysis
8.2.16.4. Strategic Initiatives

List of Tables

Table 1 North America Hyperphosphatemia Drug Market 2019-2027($ Million)
Table 2 Iron-Based Hyperphosphatemia Drug Approval Status 2014-2017
Table 3 Worldwide Population Aged 80 And Above 1950-2050 (Millions)
Table 4 Phosphorous Levels In Select Foods
Table 5 North America Hyperphosphatemia Drugs Market By Formulation 2019-2027($ Million)
Table 6 North America Calcium-Based Phosphate Binders 2019-2027($ Million)
Table 7 North America Aluminum-Based Phosphate Binders 2019-2027($ Million)
Table 8 North America Magnesium-Based Phosphate Binders 2019-2027($ Million)
Table 9 North America Iron-Based Phosphate Binders 2019-2027($ Million)
Table 10 North America Other Phosphate Binders 2019-2027($ Million)
Table 11 Pipeline Portfolio of Hyperphosphatemia Drugs
Table 12 North America Hyperphosphatemia Drugs Market 2019-2027 ($ Million)
Table 13 North America Hyperphosphatemia Drugs Market By Country 2019-2027($ Million)

List of Figures

Figure 1 Rate of Adherence To Phosphate Binders
Figure 2 Diagnosis And Clinical Indicators of Chronic Kidney Disease
Figure 3 North America Hyperphosphatemia Drugs Market By Calcium-Based Phosphate Binders 2019-2027($ Million)
Figure 4 North America Hyperphosphatemia Drugs Market By Aluminum-Based Phosphate Binders 2019-2027($ Million)
Figure 5 North America Hyperphosphatemia Drugs Market By Magnesium-Based Phosphate Binders 2019-2027($ Million)
Figure 6 North America Hyperphosphatemia Drugs Market By Iron-Based Phosphate Binders 2019-2027($ Million)
Figure 7 North America Hyperphosphatemia Drugs Market By Other Phosphate Binders 2019-2027($ Million)
Figure 8 Porters 5 Force Model of Hyperphosphatemia Market
Figure 9 North America Hyperphosphatemia Drugs Market Share, 2019 & 2027 (%)
Figure 10 North America Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 11 The United States Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 12 Canada Hyperphosphatemia Drugs Market 2019-2027($ Million)
Figure 13 Market Share Analysis of Key Players 2017 (%)
  • Global Fosfomycin Trometamol Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 21-Feb-2019        Price: US 3480 Onwards        Pages: 117
    Fosfomycin tromethamine, white or almost white crystalline powder; odorless, taste salty; Very soluble in water, dissolved in methanol, very slightly soluble in ethanol, insoluble in chloroform. Mainly for the treatment of urinary tract infections such as cystitis, urethritis. Scope of the Report: In the last several years, global market of fosfomycin trometamol developed smoothly, with an average growth rate of 7.8%. In 2015, global revenue of fosfomycin trometamol ......
  • Global Minocycline Hydrochloride Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 21-Feb-2019        Price: US 3480 Onwards        Pages: 103
    Minocycline Hydrochloride, also called minocycline HCL, is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of its long half-life it generally has serum levels 2-4 times that of the simple water-soluble tetracyclines. The CAS Number is 13614-98-7. Scope of the Report: Minocycline Hydrochloride Industry belongs to the field of medicine, ev......
  • Global Octreotide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 21-Feb-2019        Price: US 3480 Onwards        Pages: 119
    Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid. Scope of the Report: The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach 66.36% in 2015. Novartis exports to other countries mainly in the form of finished drug. The Octre......
  • Global Simethicone Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 21-Feb-2019        Price: US 3480 Onwards        Pages: 118
    Simethicone is a mixture of polydimethylsiloxane and hydrated silica gel. It is an orally administered anti-foaming agent used to reduce bloating, discomfort or pain caused by excessive gas-mainly swallowed air, with small amounts of hydrogen and methane-in the stomach or intestines. Scope of the Report: Simethicone is produced by polydimethylsiloxane and silicon dioxide at proper temperature and pressure. So, production process of simethicone is relatively simple. W......
  • Global Caffeine Market Insights, Forecast to 2025
    Published: 20-Feb-2019        Price: US 3900 Onwards        Pages: 118
    Caffeine is a bitter, white crystalline purine, methyl xanthine alkaloid, which is founded in coffee, tea, soft drinks, chocolate, kola nuts, and certain medicines. Unlike many other psychoactive substances, it is legal and unregulated in nearly all parts of the world. Caffeine is a bitter, white crystalline purine, methyl xanthine alkaloid, which is founded in coffee, tea, soft drinks, chocolate, kola nuts, and certain medicines. The types of caffeine mainly include synthesis caffeine an......
  • Global Meningococcal Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 20-Feb-2019        Price: US 3480 Onwards        Pages: 124
    Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin. Scope of the Report: Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate......
  • Global Nicotine Gum Market Insights, Forecast to 2025
    Published: 20-Feb-2019        Price: US 3900 Onwards        Pages: 119
    Global Nicotine Gum market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nicotine Gum. This report researches the worldwide Nicotine Gum market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions. ......
  • Global Antifungal Drugs Market Research Report 2019
    Published: 20-Feb-2019        Price: US 2900 Onwards        Pages: 105
    An antifungal drug, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. Such drugs are usually obtained by a doctor's prescription, but a few are available OTC (over-the-counter). Asia Pacific is expected to be the fastest growing regional segment for the antifungal drug market in 2017 within th......
  • Muscle Relaxant Drugs Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 20-Feb-2019        Price: US 3000 Onwards        Pages: 144
    Muscle Relaxant Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Muscle Relaxant Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Muscle Relaxant Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs